Safety and Pharmacokinetics of MK-7680 in Participants With Hepatitis C (MK-7680-003)
Clinical trial NCT02269059 · COMPLETED
Trial details
- NCT number
- NCT02269059
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-02-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.